RT Journal Article
T1 Long-term sequelae of drug-induced liver injury.
A1 Björnsson, Einar S
A1 Andrade, Raul J
K1 DILI
K1 cirrhosis
K1 drug-induced autoimmune hepatitis
K1 hepatotoxicity
K1 psychological disability
K1 secondary sclerosing cholangitis
K1 sinusoidal obstruction syndrome
K1 vanishing bile duct syndrome
AB Drug-induced liver injury (DILI) has a very variable clinical and biochemical phenotype and differs widely in severity, from mild injury to life-threatening liver failure. Chronic injury has also been reported to occur at a variable frequency, ranging from 3.4% to 39%, 6-12 months after discontinuing the implicated agent. This wide range is probably related to various definitions of chronic liver injury and variable selection of patients. The long-term sequalae of this chronic injury in terms of morbidity and mortality are unclear, although rare vanishing bile duct syndrome is associated with an unfavourable prognosis, with increased risk of chronic liver failure and need for liver transplantation. Other forms of long-term sequalae associated with DILI are progressive fibrosis, autoimmune-like hepatitis, secondary sclerosing cholangitis, sinusoidal obstruction syndrome and, as a common final stage, the development of cirrhosis, portal hypertension and its complications. Immune checkpoint inhibitors, which can cause an autoimmune-like phenotype have also recently been shown to cause sclerosing cholangitis with cytotoxic T CD8+ cell infiltration in biliary tracts. DILI has been shown to have a significant impact on health-related quality of life but very little is known about its psychological consequences in the long-term. Further investigations with structured long-term follow-up and periodic quality of life surveys are needed to assess the impact of DILI on psychological outcomes, particularly in those with chronic sequelae.
YR 2021
FD 2021-10-22
LK http://hdl.handle.net/10668/22311
UL http://hdl.handle.net/10668/22311
LA en
DS RISalud
RD Apr 5, 2025